PHARMACOSMOS NORWAY AS

2000 LILLESTRØM

Finances

Share Ownership

Return on Equity

12,81 %

Current Ratio

2,3

Debt-to-Equity Ratio

Key figures (NOK)	2023	2022	2021	2020
Revenue	5 925 000	4 276 000	3 362 000	4 091 000
Net Income	169 000	243 000	127 000	145 000
Total Assets	2 349 000	1 660 000	1 173 000	901 000
Total Equity	1 319 000	1 151 000	943 000	781 000

Income (NOK)	2023	2022	2021	2020
Revenue	5 925 000	4 276 000	3 362 000	4 091 000
Expenditure	5 662 000	4 074 000	3 203 000	3 896 000
Operating Profit	264 000	202 000	160 000	194 000
Financial Income	0	0	0	0
Financial Costs	0	0	0	0
Financial Balance	0	0	0	0
Earnings Before Tax	263 000	202 000	160 000	195 000
Tax	95 000	−41 000	34 000	50 000
Net Income	169 000	243 000	127 000	145 000

Balance (NOK)	2023	2022	2021	2020
Total Fixed Assets	0	0	0	0
Total Current Assets	2 349 000	1 660 000	1 173 000	901 000
Total Assets	2 349 000	1 660 000	1 173 000	901 000
Total Retained Equity	1 219 000	1 051 000	843 000	681 000
Total Equity	1 319 000	1 151 000	943 000	781 000
Total Long-Term Debt	6 000	7 000	0	−361 000
Total Current Debt	1 023 000	502 000	230 000	481 000
Total Equity and Debt	2 349 000	1 660 000	1 173 000	901 000

Cash flow (NOK)	2023	2022	2021	2020
Sales Income	5 925 000	4 234 000	3 362 000	4 091 000
Other Income	0	42 000	0	0
Revenue	5 925 000	4 276 000	3 362 000	4 091 000
Cost of Goods Sold	0	0	1 000	0
Salary Costs	4 180 000	3 257 000	2 440 000	2 810 000
Depreciation	0	0	0	0
Impairment	0	0	0	0
Expenditure	5 662 000	4 074 000	3 203 000	3 896 000
Operating Profit	264 000	202 000	160 000	194 000
Financial Income	0	0	0	0
Financial Costs	0	0	0	0
Financial Balance	0	0	0	0
Dividends	0	0	0	0
Net Income	169 000	243 000	127 000	145 000

Balance details (NOK)	2023	2022	2021	2020
Goodwill	0	0	0	0
Total Intangible Assets	0	0	0	0
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	0	0	0	0
Total Tangible Assets	0	0	0	0
Total Fiancial Fixed Assets	0	0	0	0
Total Fixed Assets	0	0	0	0
Stock	0	0	10 000	0
Total Investments	0	0	0	0
Cash, Bank	434 000	1 110 000	529 000	825 000
Total Current Assets	2 349 000	1 660 000	1 173 000	901 000
Total Assets	2 349 000	1 660 000	1 173 000	901 000
Total Equity	1 319 000	1 151 000	943 000	781 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	6 000	7 000	0	−361 000
Creditors	43 000	7 000	0	0
Unpaid Taxes	635 000	194 000	22 000	153 000
Dividends	0	0	0	0
Other Current Debt	286 000	242 000	224 000	244 000
Total Current Debt	1 023 000	502 000	230 000	481 000
Total Equity and Debt	2 349 000	1 660 000	1 173 000	901 000

Financial indicators	2023	2022	2021	2020
Return on Equity	12,81 %	21,11 %	13,47 %	18,57 %
Debt-to-Equity Ratio	0	0,01	0	−0,46
Operating Profit Margin	4,46 %	4,72 %	4,76 %	4,74 %
Current Ratio	2,3	3,31	5,1	1,87
Quick Ratio	2,3	3,31	5,33	1,87
Equity Ratio	0,56	0,69	0,8	0,87
Gross Profit Margin	100 %	100 %	99,97 %	100 %